Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients

被引:0
|
作者
B Bader-Meunier
P Hachulla
J Kuemmerle-Deschner
M Gattorno
N Patel
R Preiss
K Lheritier
T Imagawa
R Nishikomori
H Takada
T Heike
T Hara
S Yokota
机构
[1] Université Paris-Descartes and Hôpital Necker-Enfants Malades,Department of Pediatric Immunology and Rheumatology
[2] Assistance Publique Hôpitaux de Paris,undefined
[3] On behalf of the Canakinumab D2306 and D2308 study group,undefined
关键词
Japanese Patient; Western Population; Frequent Dose; Japanese Study; Sustained Response;
D O I
10.1186/1546-0096-9-S1-P12
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Diagnosis and Management of the Cryopyrin-Associated Periodic Syndromes (CAPS): What Do We Know Today?
    Welzel, Tatjana
    Kuemmerle-Deschner, Jasmin B.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (01) : 1 - 17
  • [42] Mosaicism in autoinflammatory diseases: Cryopyrin-associated periodic syndromes (CAPS) and beyond. A systematic review
    Labrousse, Marielle
    Kevorkian-Verguet, Charlotte
    Boursier, Guilaine
    Rowczenio, Dorota
    Maurier, Francois
    Lazaro, Estibaliz
    Aggarwal, Manjari
    Lemelle, Irene
    Mura, Thibault
    Belot, Alexandre
    Touitou, Isabelle
    Sarrabay, Guillaume
    [J]. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2018, 55 (06) : 432 - 442
  • [43] LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)-30-MONTH DATA FROM THE RELIANCE REGISTRY
    Kuemmerle-Deschner, J. B.
    Kortus-Goetze, B.
    Oommen, P.
    Janda, A.
    Rech, J.
    Kallinich, T.
    Weller-Heinemann, F.
    Horneff, G.
    Foeldvari, I.
    Schuetz, C.
    Borte, M.
    Braner, A.
    Weber-Arden, J.
    Blank, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 50 - 51
  • [44] Long-term safety and efficacy of Canakinumab in cryopyrin-associated periodic syndrome (CAPS) patients: Results from beta-confident registry
    Kuemmerle-Deschner J.
    Hoffman H.
    Hawkins P.N.
    van der Poll T.
    Walker U.A.
    Speziale A.
    Tilson H.H.
    [J]. Pediatric Rheumatology, 13 (Suppl 1)
  • [45] LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)-4-YEARS DATA FROM THE RELIANCE REGISTRY
    Kuemmerle-Deschner, J. B.
    Kortus-Goetze, B.
    Schuetz, C.
    Oommen, P.
    Janda, A.
    Rech, J.
    Weller-Heinemann, F.
    Kallinich, T.
    Pankow, A.
    Horneff, G.
    Foeldvari, I.
    Wasiliew, P.
    Borte, M.
    Fiene, M.
    Meier, F.
    Krickau, T.
    Andreica, I.
    Weber-Arden, J.
    Blank, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 167 - 167
  • [46] Canakinumab: a human anti-IL-1β monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes
    Church, Leigh D.
    McDermottt, Michael F.
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (06) : 831 - 841
  • [47] Characterization of NLRP3 Variants in Japanese Cryopyrin-Associated Periodic Syndrome Patients
    Ohnishi, Hidenori
    Teramoto, Takahide
    Iwata, Hiroaki
    Kato, Zenichiro
    Kimura, Takeshi
    Kubota, Kazuo
    Nishikomori, Ryuta
    Kaneko, Hideo
    Seishima, Mariko
    Kondo, Naomi
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (02) : 221 - 229
  • [48] Characterization of NLRP3 Variants in Japanese Cryopyrin-Associated Periodic Syndrome Patients
    Hidenori Ohnishi
    Takahide Teramoto
    Hiroaki Iwata
    Zenichiro Kato
    Takeshi Kimura
    Kazuo Kubota
    Ryuta Nishikomori
    Hideo Kaneko
    Mariko Seishima
    Naomi Kondo
    [J]. Journal of Clinical Immunology, 2012, 32 : 221 - 229
  • [49] THE IL-1RA ANTAGONIST KINERET® (ANAKINRA) STABILIZES HEARING LOSS IN PATIENTS WITH SEVERE CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)
    Leinonen, M.
    Soderberg, K.
    Olivecrona, H.
    Raboisson, M. Alden
    Sibley, C.
    Brewer, C.
    Plass, N.
    King, K.
    Zalewski, C.
    Kim, J.
    Stone, D.
    Chapelle, D.
    Goldbach-Mansky, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 730 - 731
  • [50] CANAKINUMAB PHARMACOKINETICS IN PATIENTS YOUNGER THAN 2 YEARS OLD WITH CRYOPYRIN ASSOCIATED PERIODIC SYNDROMES
    Kalabus, J.
    Uziel, Y.
    Brogan, P.
    Hofer, M.
    Kuemmerle-Deschner, J.
    Lauwerys, B.
    Speziale, A.
    Laxer, R.
    Lachmann, H.
    Sun, H.
    Abrams, K.
    Leon, K.
    Junge, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 849 - 849